TCL Archive NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s December 12, 1997
TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001